Overview

N-Acetyl-Cysteine for Treatment of AGA in Men

Status:
Recruiting

Trial end date:
2020-10-01

Target enrollment:

Participant gender:

Summary

To study the effectiveness and safety of the reactive oxygen species scavenger N-acetyl-cysteine (NAC) as a single therapy and in combination with the topically applied minoxidil for the treatment of the early-onset androgenetic alopecia in men.

Phase:

Phase 4

Details

Lead Sponsor:

Kafrelsheikh University

Collaborator:

Ain Shams University

Treatments:

Acetylcysteine
Minoxidil
N-monoacetylcystine